APA (7th ed.) Citation

Kurata, Y., Mouri, A., Imai, H., Endo, S., Tsukamoto, K., Masaki, K., . . . Kagamu, H. Efficacy and Safety of First-Line Nivolumab Plus Ipilimumab in Patients with Postoperative Recurrent and Inoperable Non-Small Cell Lung Cancer: A Real-World Retrospective Observational Study. MDPI AG.

Chicago Style (17th ed.) Citation

Kurata, Yuhei, et al. Efficacy and Safety of First-Line Nivolumab Plus Ipilimumab in Patients with Postoperative Recurrent and Inoperable Non-Small Cell Lung Cancer: A Real-World Retrospective Observational Study. MDPI AG.

MLA (9th ed.) Citation

Kurata, Yuhei, et al. Efficacy and Safety of First-Line Nivolumab Plus Ipilimumab in Patients with Postoperative Recurrent and Inoperable Non-Small Cell Lung Cancer: A Real-World Retrospective Observational Study. MDPI AG.